Nat Rev Immunol. 2007 Oct;7(10):790-802.

Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.

Tacken PJ, de Vries IJ, Torensma R, Figdor CG.

Source

Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Tumour Immunology, Postbox 9101, Nijmegen, 6500HB, Netherlands.

Abstract

The realization that dendritic cells (DCs) orchestrate innate and adaptive immune responses has stimulated research on harnessing DCs to create more effective vaccines. Early clinical trials exploring autologous DCs that were loaded with antigens ex vivo to induce T-cell responses have provided proof of principle. Here, we discuss how direct targeting of antigens to DC surface receptors in vivo might replace laborious and expensive ex vivo culturing, and facilitate large-scale application of DC-based vaccination therapies.

PMID:: 17853902; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Education

New England Research Institutes Inc.

Supplemental Content

Save items

Related citations in PubMed

Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody. [Blood. 2005]
Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody.
Tacken PJ, de Vries IJ, Gijzen K, Joosten B, Wu D, Rother RP, Faas SJ, Punt CJ, Torensma R, Adema GJ, et al. Blood. 2005 Aug 15; 106(4):1278-85. Epub 2005 May 5.
Review Dendritic cell vaccines for cancer immunotherapy. [Annu Rev Med. 1999]
Review Dendritic cell vaccines for cancer immunotherapy.
Timmerman JM, Levy R. Annu Rev Med. 1999; 50:507-29.
In vivo targeting of antigens to human dendritic cells through DC-SIGN elicits stimulatory immune responses and inhibits tumor growth in grafted mouse models. [J Immunother. 2007]
In vivo targeting of antigens to human dendritic cells through DC-SIGN elicits stimulatory immune responses and inhibits tumor growth in grafted mouse models.
Kretz-Rommel A, Qin F, Dakappagari N, Torensma R, Faas S, Wu D, Bowdish KS. J Immunother. 2007 Oct; 30(7):715-26.
Review Targeted antigen delivery and activation of dendritic cells in vivo: steps towards cost effective vaccines. [Semin Immunol. 2011]
Review Targeted antigen delivery and activation of dendritic cells in vivo: steps towards cost effective vaccines.
Tacken PJ, Figdor CG. Semin Immunol. 2011 Feb; 23(1):12-20. Epub 2011 Jan 26.
Review Dendritic cell-based cancer immunotherapies. [Arch Immunol Ther Exp (Warsz)....]
Review Dendritic cell-based cancer immunotherapies.
Fujii S, Takayama T, Asakura M, Aki K, Fujimoto K, Shimizu K. Arch Immunol Ther Exp (Warsz). 2009 May-Jun; 57(3):189-98. Epub 2009 May 29.

See reviews... See all...

Cited by 54 PubMed Central articles

Targeting Dendritic Cells in vivo for Cancer Therapy. [Front Immunol. 2012]
Targeting Dendritic Cells in vivo for Cancer Therapy.
Caminschi I, Maraskovsky E, Heath WR. Front Immunol. 2012; 3:13. Epub 2012 Feb 7.
Integrative analysis workflow for the structural and functional classification of C-type lectins. [BMC Bioinformatics. 2011]
Integrative analysis workflow for the structural and functional classification of C-type lectins.
Koh G, Low A, Poh D, Yao Y, Ng SK, Wong VV, Vagenende V, Lam KP, Lee DY. BMC Bioinformatics. 2011 Dec 14; 12 Suppl 14:S5. Epub 2011 Dec 14.
Direct activation of antigen-presenting cells is required for CD8+ T-cell priming and tumor vaccination. [Proc Natl Acad Sci U S A. 2011]
Direct activation of antigen-presenting cells is required for CD8+ T-cell priming and tumor vaccination.
Kratky W, Reis e Sousa C, Oxenius A, Spörri R. Proc Natl Acad Sci U S A. 2011 Oct 18; 108(42):17414-9. Epub 2011 Oct 10.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.
Nat Rev Immunol. 2007 Oct ;7(10):790-802.

PubMed
Activation of the Cdc42p GTPase by cyclin-dependent protein kinases in budding y...
Activation of the Cdc42p GTPase by cyclin-dependent protein kinases in budding yeast.
EMBO J. 2007 Oct 31 ;26(21):4487-500. Epub 2007 Sep 13 .

PubMed
Design and implementation of high-throughput RNAi screens in cultured Drosophila...
Design and implementation of high-throughput RNAi screens in cultured Drosophila cells.
Nat Protoc. 2007 ;2(9):2245-64.

PubMed
Mercury in hair as a biomarker of exposure in a coastal Venezuelan population.
Mercury in hair as a biomarker of exposure in a coastal Venezuelan population.
Invest Clin. 2007 Sep ;48(3):305-15.

PubMed
Perianal leiomyoma involving the anal sphincter.
Perianal leiomyoma involving the anal sphincter.
Ulster Med J. 2007 Sep ;76(3):173-4.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Education

Supplemental Content

Save items

Related citations in PubMed

Cited by 54 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information